|
2026
|
Invention
|
Ikzf2 positive biomarkers in cancer treatment. Provided are combination use of compounds that med... |
|
2025
|
Invention
|
Degraders of swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a... |
|
|
G/S
|
Pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, phar... |
|
|
Invention
|
Combination therapies comprising ikzf2 degrader compounds. Provided are combination use of compou... |
|
|
Invention
|
Compounds, compositions, and methods of use thereof. The present disclosure relates to compounds ... |
|
2024
|
Invention
|
Processes for making aryl compounds that modulate ikzf2 |
|
|
Invention
|
Salts and solid forms of compounds that modulate ikzf2 |
|
|
Invention
|
Processes for making aryl compounds that modulate ikzf2. The present disclosure relates generally... |
|
|
Invention
|
Salts and solid forms of compounds that modulate ikzf2. The present disclosure relates to salts a... |
|
|
Invention
|
Spirocycloalkyl compounds and pharmaceutical compositions that modulate ikzf2 |
|
|
Invention
|
Spirocycloalkyl compounds and pharmaceutical compositions that modulate ikzf2. Disclosed are comp... |
|
2023
|
Invention
|
Aryl compounds and pharmaceutical compositions that modulate ikzf2.
Disclosed are compounds and ... |
|
|
Invention
|
Compounds and pharmaceutical compositions that degrade swi/snf-related matrix-associated actin-de... |
|
|
Invention
|
Compounds and pharmaceutical compositions that degrade cdk2. This disclosure provides compounds a... |
|
|
Invention
|
Propargyl compounds and pharmaceutical compositions that modulate brd4. Disclosed are compounds o... |
|
|
Invention
|
Oligonucleotide encoded chemical libraries. This application provides a bead with a covalently at... |
|
2022
|
Invention
|
Uniform fluid flow with constant resistance and velocity. A method for fluid transport includes r... |
|
|
Invention
|
Aryl compounds and pharmaceutical compositions that modulate ikzf2. Disclosed are compounds and s... |
|
|
Invention
|
Heterocycloalkyl and heteroaryl compounds and pharmaceutical compositions that modulate ikzf2.
D... |
|
|
Invention
|
Cycloalkyl compounds and pharmaceutical compositions that modulate ikzf2.
Disclosed are compound... |
|
|
Invention
|
Cycloalkyl compounds and pharmaceutical compositions that modulate ikzf2. Disclosed are compounds... |
|
|
Invention
|
Heterocycloalkyl and heteroaryl compounds and pharmaceutical compositions that modulate ikzf2. Di... |
|
|
Invention
|
Compounds and pharmaceutical compositions that modulate brd4. Disclosed are compounds and salts t... |
|
|
Invention
|
Transfer dispensers for assay devices with bead size exclusion.
Disclosed are transfer dispenser... |
|
|
Invention
|
Transfer dispensers for assay devices with bead size exclusion. Disclosed are transfer dispensers... |
|
2021
|
Invention
|
Fluidic device and method. A microfluidic system for fluid transport is provided. The microfluidi... |
|
|
Invention
|
Fluidic device. A microfluidic system for fluid transport is provided. The microfluidic system in... |
|
|
Invention
|
Caps for assay devices. This disclosure provides for devices and methods for conduction assays fo... |
|
|
Invention
|
Caps for assay devices. An assay device including an assay device component and a biocompatible r... |
|
|
Invention
|
Assay devices for combinatorial libraries. Disclosed is an assay device comprising a high density... |
|
|
Invention
|
Quinazolinone compounds and related compounds. Disclosed are substituted quinazolinone compounds,... |
|
|
Invention
|
Oligonucleotide encoded chemical libraries, related systems, devices, and methods for detecting, ... |
|
2019
|
G/S
|
Pharmaceutical research and development |
